Skip to main content

Table 1 Baseline characteristics of study patients

From: Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients

Characteristics Event group (n = 36) Control group (n = 55) P values
Age , years, mean (standard deviation)a 53.5 (13.8) 54.4 (13.1) 0.759
Male sex, n (%) 29 (81) 46 (84) 0.781
Race, n (%)    
 Caucasian 34 (94) 54 (98) 0.560
 Other 2 (6) 1 (2) 0.560
Indication for cardiac transplantation, n (%)    
 Coronary Artery Disease 15 (42) 18 (33) 0.504
 Idiopathic Cardiomyopathy 14 (39) 30 (55) 0.198
 Valvular Heart Disease 2 (6) 3 (5) 1.000
 Acute Myocarditis 1 (3) 2 (4) 1.000
 Congenital Heart Disease 1 (3) 0 (0) 0.396
 Other indications 3 (8) 3 (4) 0.381
Use of ventricular assist device before transplantation, n (%) 6 (17) 13 (24) 0.599
Induction therapy (any), n (%) 28 (79) 45 (82) 0.784
Cytomegalovirus serology (IgG) status, n (%)    
 Donor and Recipient Positive 13 (36) 13 (24) 0.239
 Donor and Recipient Negative 7 (19) 9 (16) 0.781
 Donor Positive and Recipient Negative 3 (8) 6 (11) 1.000
 Donor Negative and Recipient Positive 6 (17) 14 (25) 0.439
 Unknown 7 (19) 13 (24) 0.797
  1. P values were calculated using two-tailed Fisher’s exact test unless indicated otherwise
  2. aTwo-sample t-test